Evidence map›Paper›PMID 26843581›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2016

Genetic and pharmacological evidence for low-abundance TRPV3 expression in primary vagal afferent neurons.

Shaw-Wen Wu, Jonathan E M Lindberg, James H Peters

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Hypoxia augments TRPM3-mediated calcium influx in vagal sensory neurons.Autonomic neuroscience : basic & clinical · 2023
    Article
  3. TRPV3 Ion Channel: From Gene to Pharmacology.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Ethyl Vanillin Activates TRPA1.The Journal of pharmacology and experimental therapeutics · 2017
    Article
  9. Effects of the Fruit Extract ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shaw-Wen WuDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington.
Jonathan E M LindbergDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington.
James H PetersDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington jamespeters@vetmed.wsu.edu.
Washington State University · US

Funding

Asynchronous Glutamate Release in Vagal Afferent to NTS NeurotransmissionR01DK092651 · NIDDK · WASHINGTON STATE UNIVERSITY · PI PETERS, JAMES HENRY · 2012 to 2016
$1.6M
NIDDK NIH HHS R01 DK092651
6 · The paper itself

Abstract

Primary vagal afferent neurons express a multitude of thermosensitive ion channels. Within this family of ion channels, the heat-sensitive capsaicin receptor (TRPV1) greatly influences vagal afferent signaling by determining the threshold for action-potential initiation at the peripheral endings, while controlling temperature-sensitive forms of glutamate release at central vagal terminals. Genetic deletion of TRPV1 does not completely eliminate these temperature-dependent effects, suggesting involvement of additional thermosensitive ion channels. The warm-sensitive, calcium-permeable, ion channel TRPV3 is commonly expressed with TRPV1; however, the extent to which TRPV3 is found in vagal afferent neurons is unknown. Here, we begin to characterize the genetic and functional expression of TRPV3 in vagal afferent neurons using molecular biology (RT-PCR and RT-quantitative PCR) in whole nodose and isolated neurons and fluorescent calcium imaging on primary cultures of nodose ganglia neurons. We confirmed low-level TRPV3 expression in vagal afferent neurons and observed direct activation with putative TRPV3 agonists eugenol, ethyl vanillin (EVA), and farnesyl pyrophosphate (FPP). Agonist activation stimulated neurons also containing TRPV1 and was blocked by ruthenium red. FPP sensitivity overlapped with EVA and eugenol but represented the smallest percentage of vagal afferent neurons, and it was the only agonist that did not stimulate neurons from TRPV3(-/-1) mice, suggesting FPP has the highest selectivity. Further, FPP was predictive of enhanced responses to capsaicin, EVA, and eugenol in rats. From our results, we conclude TRPV3 is expressed in a discrete subpopulation of vagal afferent neurons and may contribute to vagal afferent signaling either directly or in combination with TRPV1.

Indexed as

AnimalsCells, CulturedGene Expression RegulationMaleMiceMice, Inbred C57BLMice, KnockoutNeurons, AfferentNodose GanglionRatsRats, Sprague-DawleyRNA, MessengerTRPV Cation ChannelsVagus NerveRNA, MessengerTRPV1 protein, mouseTrpv1 protein, ratTrpv3 protein, mouseTRPV3 protein, ratTRPV Cation Channelsautonomic reflexescalciumnodose ganglionsatietyvagus

Identifiers

PMID26843581
PMCPMC5000774
OpenAlexW2264889337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.